CCP
AMGN icon

Corient Capital Partners’s Amgen AMGN Stock Holding History

Corient Capital Partners’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$6.49M Hold
26,680
– – 0.49% 47
2022
Q2 		$6.49M Buy
26,680
+2,316
+10% +$568K 0.49% 49
2022
Q1 		$5.89M Buy
24,364
+1,392
+6% +$320K 0.39% 57
2021
Q4 		$5.17M Sell
22,972
-7,434
-24% -$1.57M 0.34% 69
2021
Q3 		$6.47M Buy
30,406
+545
+2% +$125K 0.47% 50
2021
Q2 		$7.28M Buy
29,861
+1,682
+6% +$414K 0.53% 44
2021
Q1 		$7.01M Buy
28,179
+894
+3% +$213K 0.6% 39
2020
Q4 		$6.27M Buy
27,285
+649
+2% +$150K 0.63% 37
2020
Q3 		$6.77M Sell
26,636
-520
-2% -$129K 0.78% 26
2020
Q2 		$6.41M Sell
27,156
-2,382
-8% -$543K 0.78% 28
2020
Q1 		$5.99M Buy
29,538
+2,250
+8% +$491K 0.94% 20
2019
Q4 		$6.58M Buy
27,288
+2,739
+11% +$604K 0.84% 21
2019
Q3 		$4.75M Buy
24,549
+286
+1% +$54.9K 0.67% 30
2019
Q2 		$4.47M Sell
24,263
-2,533
-9% -$454K 0.69% 28
2019
Q1 		$5.09M Sell
26,796
-7,764
-22% -$1.48M 0.83% 16
2018
Q4 		$6.73M Sell
34,560
-1,288
-4% -$251K 1.2% 10
2018
Q3 		$7.43M Hold
35,848
– – 1.24% 7
2018
Q2 		$6.62M Sell
35,848
-329
-0.9% -$58.2K 1.15% 7
2018
Q1 		$6.17M Sell
36,177
-453
-1% -$83.2K 1.14% 9
2017
Q4 		$6.37M Buy
36,630
+29,051
+383% +$5.14M 1.08% 14
2017
Q3 		$1.41M Sell
7,579
-5,765
-43% -$1.02M 0.27% 93
2017
Q2 		$2.3M Buy
13,344
+227
+2% +$36.9K 0.35% 85
2017
Q1 		$2.15M Buy
13,117
+5,943
+83% +$987K 0.34% 88
2016
Q4 		$1.05M Sell
7,174
-1,638
-19% -$247K 0.19% 122
2016
Q3 		$1.47M Buy
+8,812
New +$1.49M 0.27% 99

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Corient Capital Partners's AMGN Position: Q3 2022 in Review

Corient Capital Partners held its Amgen (AMGN) position steady in Q3 2022 at 26,680 shares worth $6.49M. The position accounts for 0.49% of the portfolio, ranked #47.

Corient Capital Partners first reported a position in AMGN in Q3 2016 and has held it in 25 quarters since. The position peaked at $7.43M in Q3 2018. 2,322 funds tracked by Wall St. Rank hold AMGN as of Q3 2022.

  • Corient Capital Partners held 26,680 shares of Amgen worth $6.49M as of Q3 2022.
  • Corient Capital Partners left its Amgen share count unchanged in Q3 2022.
  • Amgen made up 0.49% of Corient Capital Partners's portfolio in Q3 2022, its #47 holding.
  • Corient Capital Partners first reported a position in Amgen in Q3 2016 and has held it in 25 quarters since.
  • Corient Capital Partners's Amgen position peaked at $7.43M in Q3 2018.
  • 2,322 funds tracked by Wall St. Rank held Amgen as of Q3 2022.

Based on Corient Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.